BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30798456)

  • 21. K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions.
    Ostrem JM; Peters U; Sos ML; Wells JA; Shokat KM
    Nature; 2013 Nov; 503(7477):548-51. PubMed ID: 24256730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conformational states of ADP ribosylation factor 1 complexed with different guanosine triphosphates as studied by 31P NMR spectroscopy.
    Meierhofer T; Eberhardt M; Spoerner M
    Biochemistry; 2011 Jul; 50(29):6316-27. PubMed ID: 21702511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conformational Dynamics Allows Sampling of an "Active-like" State by Oncogenic K-Ras-GDP.
    Grudzien P; Jang H; Leschinsky N; Nussinov R; Gaponenko V
    J Mol Biol; 2022 Sep; 434(17):167695. PubMed ID: 35752212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In situ selectivity profiling and crystal structure of SML-8-73-1, an active site inhibitor of oncogenic K-Ras G12C.
    Hunter JC; Gurbani D; Ficarro SB; Carrasco MA; Lim SM; Choi HG; Xie T; Marto JA; Chen Z; Gray NS; Westover KD
    Proc Natl Acad Sci U S A; 2014 Jun; 111(24):8895-900. PubMed ID: 24889603
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Huang Q; Ng EY; Li Q; Kang C
    Biomol NMR Assign; 2022 Apr; 16(1):51-56. PubMed ID: 34787842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequential assignment of the backbone nuclei (1H, 15N and 13C) of c-H-ras p21 (1-166).GDP using a novel 4D NMR strategy.
    Campbell-Burk SL; Domaille PJ; Starovasnik MA; Boucher W; Laue ED
    J Biomol NMR; 1992 Nov; 2(6):639-46. PubMed ID: 1337001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guanine-nucleotide binding activity, interaction with GTPase-activating protein and solution conformation of the human c-Ha-Ras protein catalytic domain are retained upon deletion of C-terminal 18 amino acid residues.
    Fujita-Yoshigaki J; Ito Y; Yamasaki K; Muto Y; Miyazawa T; Nishimura S; Yokoyama S
    J Protein Chem; 1992 Dec; 11(6):731-9. PubMed ID: 1466766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural insight into the rearrangement of the switch I region in GTP-bound G12A K-Ras.
    Xu S; Long BN; Boris GH; Chen A; Ni S; Kennedy MA
    Acta Crystallogr D Struct Biol; 2017 Dec; 73(Pt 12):970-984. PubMed ID: 29199977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. K-Ras Populates Conformational States Differently from Its Isoform H-Ras and Oncogenic Mutant K-RasG12D.
    Parker JA; Volmar AY; Pavlopoulos S; Mattos C
    Structure; 2018 Jun; 26(6):810-820.e4. PubMed ID: 29706533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Solid-state 31P NMR spectroscopy of microcrystals of the Ras protein and its effector loop mutants: comparison between crystalline and solution state.
    Iuga A; Spoerner M; Kalbitzer HR; Brunner E
    J Mol Biol; 2004 Sep; 342(3):1033-40. PubMed ID: 15342254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct dynamics and interaction patterns in H- and K-Ras oncogenic P-loop mutants.
    Sayyed-Ahmad A; Prakash P; Gorfe AA
    Proteins; 2017 Sep; 85(9):1618-1632. PubMed ID: 28498561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An NMR comparison of the changes produced by different guanosine 5'-triphosphate analogs in wild-type and oncogenic mutant p21ras.
    Miller AF; Halkides CJ; Redfield AG
    Biochemistry; 1993 Jul; 32(29):7367-76. PubMed ID: 8338834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Excited-state observation of active K-Ras reveals differential structural dynamics of wild-type versus oncogenic G12D and G12C mutants.
    Hansen AL; Xiang X; Yuan C; Bruschweiler-Li L; Brüschweiler R
    Nat Struct Mol Biol; 2023 Oct; 30(10):1446-1455. PubMed ID: 37640864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrinsic GTPase Activity of K-RAS Monitored by Native Mass Spectrometry.
    Moghadamchargari Z; Huddleston J; Shirzadeh M; Zheng X; Clemmer DE; M Raushel F; Russell DH; Laganowsky A
    Biochemistry; 2019 Aug; 58(31):3396-3405. PubMed ID: 31306575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2'-Deoxy Guanosine Nucleotides Alter the Biochemical Properties of Ras.
    Yun SD; Scott E; Moghadamchargari Z; Laganowsky A
    Biochemistry; 2023 Aug; 62(16):2450-2460. PubMed ID: 37487239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three-dimensional structure of p21H-ras and its implications.
    Wittinghofer F
    Semin Cancer Biol; 1992 Aug; 3(4):189-98. PubMed ID: 1421163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optical Control of the GTP Affinity of K-Ras(G12C) by a Photoswitchable Inhibitor.
    Ge Z; Yang Z; Liang J; Dong D; Zhu M
    Chembiochem; 2019 Dec; 20(23):2916-2920. PubMed ID: 31219673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The higher level of complexity of K-Ras4B activation at the membrane.
    Jang H; Banerjee A; Chavan TS; Lu S; Zhang J; Gaponenko V; Nussinov R
    FASEB J; 2016 Apr; 30(4):1643-55. PubMed ID: 26718888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nucleotide binding and GTP hydrolysis by the 21-kDa product of the c-H-ras gene as monitored by proton-NMR spectroscopy.
    Löw A; Sprinzl M; Limmer S
    Eur J Biochem; 1993 Apr; 213(2):781-8. PubMed ID: 8386636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Site-directed mutagenesis, fluorescence, and two-dimensional NMR studies on microenvironments of effector region aromatic residues of human c-Ha-Ras protein.
    Yamasaki K; Shirouzu M; Muto Y; Fujita-Yoshigaki J; Koide H; Ito Y; Kawai G; Hattori S; Yokoyama S; Nishimura S
    Biochemistry; 1994 Jan; 33(1):65-73. PubMed ID: 8286364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.